This is the Guardian. Last week, leveling up Minister Deanna Davison resigned from government, not because of

a scandal or a spat, but something more surprising.

The reason that I quit two weeks ago as a minister, I was leveling up minister in the government

was because I struggle with chronic migraine and it reached a point where it felt that I wasn't doing the

job to the level that it needed. She's not alone. It's estimated that one in seven

adults in the UK gets migraines, myself included.

In fact, migraine is the third most common disorder in the world

and the third highest cause of disability.

To be in a position where you're giving speeches or responding to questions in the House of Commons

Chamber, struggling to form sentences, it's just not good. Yeah.

Here in the UK, a new drug has just been recommended that might bring hope for people who haven't

responded to other medication. So today we're exploring the latest science on

migraines and their treatments and asking whether one day sufferers could say

goodbye to migraines forever.

From the Guardian, I'm Madeline Finley, and this is Science Weekly. Peter Godesby, your director of NIHR King's Clinical Research Facility and Professor of of Neurology at King's College London,

and you've been described as the man forcing the world to take migraines seriously.

Do you think treating migraines should be a bigger priority?

Oh yes, treating migrain certainly should be a bigger priority.

It might surprise you to know that migraine is the commonest neurologic problem that goes to general practice, is the

commonest neurological problem referred to secondary care neurology.

Yet it is at the bottom of the list when it comes to specialized clinics around the country to deal with

migrant. So it's substantially being ignored. It typically strikes down people between the age of 18 and about

...